Camilla Day is currently a General Adult Psychiatry Registrar at South London and Maudsley NHS Trust working in a therapeutic community. She is also doing a part-time MD(Res) within the Centre for Affective Disorders, IOPPN, King’s College London, investigating the role of self-compassion, phenomenology, and the therapeutic relationship in psilocybin’s effect in TRD via quantitative and qualitative methods. She is currently developing a Compassion Experience Scale in Psilocybin for Treatment-Resistant Depression.
CV
Dr. Camilla Day was the lead female psychiatrist for the Imperial pilot study of psilocybin in treatment-resistant depression (TRD) led by Robin Carhartt-Harris. She supported 11 out of the 20 people with TRD, each through two dosing sessions, and collaborated with Rosalind Watts on her qualitative research.
She runs a Phenomenology reading group for London psychiatric trainees and has an interest in mindfulness and dance movement therapy.
She is half Finnish and half English, grew up in Jersey, and now lives with her Argentinian husband with their 2-year-old daughter in London.
Notable Research Papers
- Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study (Carhart-Harris, Day, et al., 2016)
- Psilocybin with psychological support for treatment-resistant depression: six-month follow-up (Carhart-Harris, Day, et al., 2018)
- Patients’ accounts of increased “connectedness” and “acceptance” after psilocybin for treatment-resistant depression (Watts, Day, et al., 2017)
Find more on ResearchGate or PubMed
In our database you will also find her as an author on many more papers.
Explore more info with a membership (any level)
🧑 Extended profile information
📈 In-depth psychedelic reports (Sprout & Tree)
🪄 Weekly psychedelic research & implementation newsletter (free)